OFLOXACIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ofloxacin, and what generic alternatives are available?
Ofloxacin is a drug marketed by Bedford, Altaire Pharms Inc, Alvogen, Amneal, Apotex Inc, Bausch And Lomb, Caplin, Epic Pharma Llc, Fdc Ltd, Mankind Pharma, Sandoz, Sentiss, Somerset, Hikma, Cadila Pharms Ltd, Dr Reddys Labs Ltd, Larken Labs, Ranbaxy Labs Ltd, and Teva. and is included in twenty-eight NDAs.
The generic ingredient in OFLOXACIN is ofloxacin. There are seventy-eight drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the ofloxacin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ofloxacin
A generic version of OFLOXACIN was approved as ofloxacin by LARKEN LABS on September 2nd, 2003.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for OFLOXACIN?
- What are the global sales for OFLOXACIN?
- What is Average Wholesale Price for OFLOXACIN?
Summary for OFLOXACIN
| US Patents: | 0 |
| Applicants: | 19 |
| NDAs: | 28 |
| Finished Product Suppliers / Packagers: | 29 |
| Raw Ingredient (Bulk) Api Vendors: | 167 |
| Clinical Trials: | 37 |
| Patent Applications: | 3,561 |
| Drug Prices: | Drug price information for OFLOXACIN |
| Drug Sales Revenues: | Drug sales revenues for OFLOXACIN |
| DailyMed Link: | OFLOXACIN at DailyMed |
Recent Clinical Trials for OFLOXACIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| IVIEW Therapeutics Inc. | Phase 2 |
| Jagiellonian University | N/A |
| Centre Hospitalier Universitaire, Amiens | N/A |
Pharmacology for OFLOXACIN
| Drug Class | Quinolone Antimicrobial |
Medical Subject Heading (MeSH) Categories for OFLOXACIN
Anatomical Therapeutic Chemical (ATC) Classes for OFLOXACIN
US Patents and Regulatory Information for OFLOXACIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Larken Labs | OFLOXACIN | ofloxacin | TABLET;ORAL | 076093-003 | Sep 2, 2003 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Dr Reddys Labs Ltd | OFLOXACIN | ofloxacin | TABLET;ORAL | 077098-002 | Feb 10, 2006 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Ranbaxy Labs Ltd | OFLOXACIN | ofloxacin | TABLET;ORAL | 076220-001 | Sep 2, 2003 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Dr Reddys Labs Ltd | OFLOXACIN | ofloxacin | TABLET;ORAL | 077098-003 | Feb 10, 2006 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Bedford | OFLOXACIN | ofloxacin | INJECTABLE;INJECTION | 075762-001 | Jan 16, 2002 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bausch And Lomb | OFLOXACIN | ofloxacin | SOLUTION/DROPS;OTIC | 076128-001 | Mar 17, 2008 | AT | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Cadila Pharms Ltd | OFLOXACIN | ofloxacin | TABLET;ORAL | 091656-001 | Sep 18, 2014 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
